BackSanthera Pharmaceuticals Holding AG Overview

Santhera Pharmaceuticals Holding AG Current Cash

Santhera Pharmaceuticals Holding AG's current cash is $42M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$41.77M
↑ 127.04% YoYΔ $23.37M vs prior year quarter

Peer trimmed avg / median

Loading

Santhera Pharmaceuticals Holding AG Current Cash History

Loading

Santhera Pharmaceuticals Holding AG vs. peers: Current Cash Comparison

Loading

Santhera Pharmaceuticals Holding AG Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Santhera Pharmaceuticals Holding AG (SPHDF) FAQ

As of the most recent data (June 2026), SPHDF shows a current cash of $42M. That compares with $18M in the prior-year period — up 127.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SPHDF's current cash is now $42M (was $18M) — a 127.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Santhera Pharmaceuticals Holding AG is outperforming or lagging.

Tracking SPHDF's current cash over time shows whether Santhera Pharmaceuticals Holding AG is scaling, shrinking, or reshaping that part of the business. The current reading is $42M That compares with $18M in the prior-year period — up 127.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Santhera Pharmaceuticals Holding AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $42M) with ownership activity and broader fundamentals.

Santhera Pharmaceuticals Holding AG's current cash is $42M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.